2m 2m 2m 2m 2m 2m 2m
Codexis (CDXS)
NASDAQ
$2.67-$0.02 (-0.67%)
Price as of Jun 03, 2026 7:56 PM EDT- $251.8MMarket Cap
- 14.96%1-Year Change
- BiotechnologyIndustry
Codexis (CDXS)
$2.67-$0.02 (-0.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 26.0M -56.14% | 59.3M -15.39% | 70.1M -49.39% | 138.6M +32.30% | |
Cost of Revenue | 9.3M -42.67% | 16.3M +27.16% | 12.8M -66.32% | 38.0M +71.25% | |
Gross Profit | 16.7M -61.24% | 43.1M -24.90% | 57.3M -42.98% | 100.6M +21.82% | |
Sales and Marketing Expense | 47.1M -14.64% | 55.1M +3.56% | 53.3M +2.07% | 52.2M +5.78% | |
Research and Development Expense | -52.3M +13.06% | -46.3M -21.44% | -58.9M -26.48% | -80.1M +43.24% | |
Depreciation and Amortization Expense | 5.2M +6.11% | 4.9M -10.37% | 5.5M +2.15% | 5.4M +73.53% | |
Total Operating Expenses | 112.1M -4.87% | 117.9M -14.72% | 138.2M -20.33% | 173.5M +36.11% | |
Operating Profit | -41.7M -28.67% | -58.5M -14.03% | -68.1M +95.15% | -34.9M +53.68% | |
Interest Income | 2.6M -28.47% | 3.7M -12.03% | 4.2M +189.52% | 1.4M +213.94% | |
Interest Expense | -4.5M +28.57% | -3.5M N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.9M -1,202.94% | 170,000 -95.93% | 4.2M +189.52% | 1.4M +213.94% | |
Total Nonoperating Income and Expense | -4.8M -53.69% | -10.4M -15.33% | -12.3M -9,998.39% | 124,000 -89.20% | |
Income before Taxes | -43.9M -32.67% | -65.2M -14.35% | -76.2M +128.63% | -33.3M +57.97% | |
Income Taxes | 47,000 +38.24% | 34,000 -50.72% | 69,000 -75.00% | 276,000 +46.03% | |
Extraordinary Items | 0 -100.00% | 165,000 -89.00% | 1.5M N/A | N/A N/A | |
Net Income | -44.0M -32.63% | -65.3M -14.38% | -76.2M +126.96% | -33.6M +57.86% | |
Net Income from Continuing Operations Applicable to Common | -43.9M -32.67% | -65.2M -14.35% | -76.2M +128.63% | -33.3M +57.97% | |
Basic EPS and Net Income | -0.50 -43.82% | -0.89 -20.54% | -1.12 +119.61% | -0.51 +54.55% | |
Diluted EPS and Net Income | -0.50 -43.82% | -0.89 -20.54% | -1.12 +119.61% | -0.51 +54.55% | |
Basic Weighted Average Shares | 87.1M +18.71% | 73.4M +7.75% | 68.1M +4.27% | 65.3M +1.20% | |
Diluted Weighted Average Shares | 87.1M +18.71% | 73.4M +7.75% | 68.1M +4.27% | 65.3M +1.20% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 50.8M +163.67% | 19.3M -70.42% | 65.1M -42.87% | 114.0M -2.41% | |
Short-Term Investments | 27.4M -49.41% | 54.2M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 78.2M +6.47% | 73.5M +12.81% | 65.1M -42.87% | 114.0M -2.41% | |
Total Current Assets | 96.8M -1.98% | 98.8M +5.68% | 93.5M -42.62% | 162.9M +0.62% | |
Accumulated Depreciation | 45.2M +10.52% | 40.9M +4.13% | 39.3M -1.28% | 39.8M +10.98% | |
Property and Plant and Equipment and Net | 13.0M -8.26% | 14.2M -8.33% | 15.5M -31.52% | 22.6M +5.95% | |
Total Long-Term Assets | 883,000 -13.35% | 1.0M -18.22% | 1.2M +256.00% | 350,000 +26.81% | |
Total Assets | 147.8M -0.81% | 149.0M +9.12% | 136.6M -45.46% | 250.4M +1.63% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 25.3M +7.06% | 23.6M -34.00% | 35.8M -26.98% | 49.1M +47.03% | |
Total Long-Term Debt | 40.1M +38.75% | 28.9M +2,123.46% | 1.3M 0.00% | 1.3M 0.00% | |
Total Long-Term Liabilities | 1.3M +4.65% | 1.3M +2.84% | 1.2M -10.07% | 1.4M +4.58% | |
Total Liabilities | 97.3M +18.50% | 82.1M +64.35% | 49.9M -52.70% | 105.6M +28.79% | |
Retained Earnings | -606.8M +7.81% | -562.8M +13.12% | -497.5M +18.10% | -421.3M +8.66% | |
Total Stockholders Equity | 50.5M -24.50% | 66.9M -22.73% | 86.6M -40.18% | 144.8M -11.92% | |
Total Shares Outstanding | 90.5M +10.54% | 81.8M +17.09% | 69.9M +6.22% | 65.8M +1.08% | |
Cash Flow | |||||
Cash from Operating Activities | -19.4M -60.79% | -49.4M -6.13% | -52.6M -566.48% | 11.3M +179.09% | |
Capital Expenditures | 4.5M +3.86% | 4.3M -2.56% | 4.4M -46.82% | 8.3M -39.93% | |
Cash from Investing Activities | 23.5M +141.25% | -57.0M +1,072.91% | -4.9M -64.22% | -13.6M -36.62% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 27.9M -53.85% | 60.5M +641.06% | 8.2M +1,520.35% | -575,000 -115.26% | |
Financials Ratio | |||||
Gross Margin | 64.12% -11.62% | 72.55% -11.24% | 81.74% +12.65% | 72.56% -7.92% | |
Operating Margin | -160.36% +62.63% | -98.61% +1.61% | -97.04% +285.57% | -25.17% +16.16% | |
Return on Assets | -29.63% -35.18% | -45.72% +16.02% | -39.41% +191.37% | -13.52% +48.73% | |
Return on Equity | -74.88% -11.94% | -85.03% +29.04% | -65.89% +203.24% | -21.73% +70.79% | |
Revenue Growth | -56.14% +264.69% | -15.39% -68.83% | -49.39% -252.90% | 32.30% -37.52% | |
Current Ratio | 3.82 -8.44% | 4.18 +60.12% | 2.61 -21.43% | 3.32 -31.57% | |
Cash Ratio | 2.01 +146.29% | 0.81 -55.18% | 1.82 -21.77% | 2.32 -33.63% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow